Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
10.9M
-
Number of holders
-
195
-
Total 13F shares, excl. options
-
10.5M
-
Shares change
-
+135K
-
Total reported value, excl. options
-
$733M
-
Value change
-
+$10.6M
-
Put/Call ratio
-
0.51
-
Number of buys
-
96
-
Number of sells
-
-75
-
Price
-
$69.81
Significant Holders of MEDIFAST INC - Common Stock, $0.001 par value per share (MED) as of Q4 2017
219 filings reported holding MED - MEDIFAST INC - Common Stock, $0.001 par value per share as of Q4 2017.
MEDIFAST INC - Common Stock, $0.001 par value per share (MED) has 195 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.5M shares
of 10.9M outstanding shares and own 96.23% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.58M shares), RENAISSANCE TECHNOLOGIES LLC (956K shares), Vanguard Group Inc (712K shares), DIMENSIONAL FUND ADVISORS LP (695K shares), ACADIAN ASSET MANAGEMENT LLC (459K shares), STATE STREET CORP (350K shares), AMERICAN CENTURY COMPANIES INC (294K shares), Engaged Capital LLC (265K shares), Numeric Investors LLC (217K shares), and ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (190K shares).
This table shows the top 195 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.